title: Authors’ response to Persson C: primary lysis/necrosis of eosinophils and clinical control of asthma.
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Fattahi
authors.forename: Franke
authors.initials: F
authors.lastname: Volbeda
authors.forename: Martine
authors.initials: M
authors.lastname: Broekema
authors.forename: Monique E
authors.initials: ME
authors.lastname: Lodewijk
authors.forename: Machteld N
authors.initials: MN
authors.lastname: Hylkema
authors.forename: Helen K
authors.initials: HK
authors.lastname: Reddel
authors.forename: Wim
authors.initials: W
authors.lastname: Timens
authors.forename: Dirkje S
authors.initials: DS
authors.lastname: Postma
authors.forename: Nick H T
authors.initials: NH
authors.lastname: ten Hacken
mesh_terms: D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy* / Q000473:pathology*; D004802:Eosinophilia / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D008297:Male; D009569:Nitric Oxide / Q000032:analysis*
chemical_list: D018927:Anti-Asthmatic Agents; D009569:Nitric Oxide